351 related articles for article (PubMed ID: 26253870)
1. CD73 Expression Is an Independent Prognostic Factor in Prostate Cancer.
Leclerc BG; Charlebois R; Chouinard G; Allard B; Pommey S; Saad F; Stagg J
Clin Cancer Res; 2016 Jan; 22(1):158-66. PubMed ID: 26253870
[TBL] [Abstract][Full Text] [Related]
2. Specific blockade CD73 alters the "exhausted" phenotype of T cells in head and neck squamous cell carcinoma.
Deng WW; Li YC; Ma SR; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
Int J Cancer; 2018 Sep; 143(6):1494-1504. PubMed ID: 29663369
[TBL] [Abstract][Full Text] [Related]
3. CD73 acts as a prognostic biomarker and promotes progression and immune escape in pancreatic cancer.
Chen Q; Pu N; Yin H; Zhang J; Zhao G; Lou W; Wu W
J Cell Mol Med; 2020 Aug; 24(15):8674-8686. PubMed ID: 32643277
[TBL] [Abstract][Full Text] [Related]
4. Targeting CD73 enhances the antitumor activity of anti-PD-1 and anti-CTLA-4 mAbs.
Allard B; Pommey S; Smyth MJ; Stagg J
Clin Cancer Res; 2013 Oct; 19(20):5626-35. PubMed ID: 23983257
[TBL] [Abstract][Full Text] [Related]
5. Potential prognostic biomarker CD73 regulates epidermal growth factor receptor expression in human breast cancer.
Zhi X; Wang Y; Yu J; Yu J; Zhang L; Yin L; Zhou P
IUBMB Life; 2012 Nov; 64(11):911-20. PubMed ID: 23086814
[TBL] [Abstract][Full Text] [Related]
6. CD73 is associated with poor prognosis in high-grade serous ovarian cancer.
Turcotte M; Spring K; Pommey S; Chouinard G; Cousineau I; George J; Chen GM; Gendoo DM; Haibe-Kains B; Karn T; Rahimi K; Le Page C; Provencher D; Mes-Masson AM; Stagg J
Cancer Res; 2015 Nov; 75(21):4494-503. PubMed ID: 26363007
[TBL] [Abstract][Full Text] [Related]
7. High intratumoral CD8
Yang Y; Attwood K; Bshara W; Mohler JL; Guru K; Xu B; Kalinski P; Chatta G
Prostate; 2021 Jan; 81(1):20-28. PubMed ID: 33085799
[TBL] [Abstract][Full Text] [Related]
8. Large-scale independent validation of the nuclear factor-kappa B p65 prognostic biomarker in prostate cancer.
Gannon PO; Lessard L; Stevens LM; Forest V; Bégin LR; Minner S; Tennstedt P; Schlomm T; Mes-Masson AM; Saad F
Eur J Cancer; 2013 Jul; 49(10):2441-8. PubMed ID: 23541563
[TBL] [Abstract][Full Text] [Related]
9. CD73-mediated adenosine production promotes stem cell-like properties in mouse Tc17 cells.
Flores-Santibáñez F; Fernández D; Meza D; Tejón G; Vargas L; Varela-Nallar L; Arredondo S; Guixé V; Rosemblatt M; Bono MR; Sauma D
Immunology; 2015 Dec; 146(4):582-94. PubMed ID: 26331349
[TBL] [Abstract][Full Text] [Related]
10. Inducible nitric oxide synthase (iNOS) expression and its prognostic value in prostate cancer.
Aaltoma SH; Lipponen PK; Kosma VM
Anticancer Res; 2001; 21(4B):3101-6. PubMed ID: 11712818
[TBL] [Abstract][Full Text] [Related]
11. High expression of CD73 as a poor prognostic biomarker in human colorectal cancer.
Wu XR; He XS; Chen YF; Yuan RX; Zeng Y; Lian L; Zou YF; Lan N; Wu XJ; Lan P
J Surg Oncol; 2012 Aug; 106(2):130-7. PubMed ID: 22287455
[TBL] [Abstract][Full Text] [Related]
12. Infiltration of CD8+ lymphocytes is an independent prognostic factor of biochemical failure-free survival in prostate cancer.
Ness N; Andersen S; Valkov A; Nordby Y; Donnem T; Al-Saad S; Busund LT; Bremnes RM; Richardsen E
Prostate; 2014 Oct; 74(14):1452-61. PubMed ID: 25111810
[TBL] [Abstract][Full Text] [Related]
13. The expression and clinical significance of CD73 molecule in human rectal adenocarcinoma.
Zhang B; Song B; Wang X; Chang XS; Pang T; Zhang X; Yin K; Fang GE
Tumour Biol; 2015 Jul; 36(7):5459-66. PubMed ID: 25677906
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the expression of interleukins, interferon β, and nuclear factor-κ B in prostate cancer and their relationship with biochemical recurrence.
Eiró N; Bermudez-Fernandez S; Fernandez-Garcia B; Atienza S; Beridze N; Escaf S; Vizoso FJ
J Immunother; 2014 Sep; 37(7):366-73. PubMed ID: 25075566
[TBL] [Abstract][Full Text] [Related]
15. CD73 on cancer-associated fibroblasts enhanced by the A
Yu M; Guo G; Huang L; Deng L; Chang CS; Achyut BR; Canning M; Xu N; Arbab AS; Bollag RJ; Rodriguez PC; Mellor AL; Shi H; Munn DH; Cui Y
Nat Commun; 2020 Jan; 11(1):515. PubMed ID: 31980601
[TBL] [Abstract][Full Text] [Related]
16. Highly expressed tumoral emmprin and stromal CD73 predict a poor prognosis for external auditory canal carcinoma.
Miyazaki M; Aoki M; Okado Y; Koga K; Hamasaki M; Nakagawa T; Sakata T; Nabeshima K
Cancer Sci; 2020 Aug; 111(8):3045-3056. PubMed ID: 32473077
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of CD73 expression and its relationship to PD-L1 in patients with radically treated pancreatic cancer.
Tahkola K; Ahtiainen M; Kellokumpu I; Mecklin JP; Laukkarinen J; Laakkonen J; Kenessey I; Jalkanen S; Salmi M; Böhm J
Virchows Arch; 2021 Feb; 478(2):209-217. PubMed ID: 32676968
[TBL] [Abstract][Full Text] [Related]
18. Impact of the EpCAM expression on biochemical recurrence-free survival in clinically localized prostate cancer.
Benko G; Spajić B; Krušlin B; Tomas D
Urol Oncol; 2013 May; 31(4):468-74. PubMed ID: 21514185
[TBL] [Abstract][Full Text] [Related]
19. CD73 is associated with poor prognosis in HNSCC.
Ren ZH; Lin CZ; Cao W; Yang R; Lu W; Liu ZQ; Chen YM; Yang X; Tian Z; Wang LZ; Li J; Wang X; Chen WT; Ji T; Zhang CP
Oncotarget; 2016 Sep; 7(38):61690-61702. PubMed ID: 27557512
[TBL] [Abstract][Full Text] [Related]
20. Ecto-5'-nucleotidase/CD73 enhances endothelial barrier function and sprouting in blood but not lymphatic vasculature.
Yegutkin GG; Auvinen K; Rantakari P; Hollmén M; Karikoski M; Grénman R; Elima K; Jalkanen S; Salmi M
Eur J Immunol; 2015 Feb; 45(2):562-73. PubMed ID: 25402681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]